115 related articles for article (PubMed ID: 23416464)
1. RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras.
Tso PH; Wang Y; Yung LY; Tong Y; Lee MM; Wong YH
Cell Signal; 2013 May; 25(5):1064-74. PubMed ID: 23416464
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.
Wang Y; Tong Y; Tso PH; Wong YH
Cancer Lett; 2013 Oct; 339(1):33-41. PubMed ID: 23911936
[TBL] [Abstract][Full Text] [Related]
3. RGS19 stimulates cell proliferation by deregulating cell cycle control and enhancing Akt signaling.
Tso PH; Yung LY; Wang Y; Wong YH
Cancer Lett; 2011 Oct; 309(2):199-208. PubMed ID: 21705135
[TBL] [Abstract][Full Text] [Related]
4. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
5. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
6. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
7. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
[TBL] [Abstract][Full Text] [Related]
8. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
9. RGS19 enhances cell proliferation through its C-terminal PDZ motif.
Tso PH; Wang Y; Wong SY; Poon LS; Chan AS; Wong YH
Cell Signal; 2010 Nov; 22(11):1700-7. PubMed ID: 20599498
[TBL] [Abstract][Full Text] [Related]
10. Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3.
Wang X; Studzinski GP
J Cell Physiol; 2004 Mar; 198(3):333-42. PubMed ID: 14755538
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19.
Wang Q; Terauchi A; Yee CH; Umemori H; Traynor JR
Cell Signal; 2014 Sep; 26(9):1846-52. PubMed ID: 24793302
[TBL] [Abstract][Full Text] [Related]
14. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
Arai A; Aoki M; Weihua Y; Jin A; Miura O
Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
[TBL] [Abstract][Full Text] [Related]
15. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
16. Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis.
Tong Y; Yung LY; Wong YH
Cancer Lett; 2015 Jun; 361(2):207-17. PubMed ID: 25748386
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
18. Activation of Ras-dependent signaling pathways by G(14) -coupled receptors requires the adaptor protein TPR1.
Kwan DH; Yung LY; Ye RD; Wong YH
J Cell Biochem; 2012 Nov; 113(11):3486-97. PubMed ID: 22711498
[TBL] [Abstract][Full Text] [Related]
19. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
20. Myosin light chain kinase and acto-myosin contractility modulate activation of the ERK cascade downstream of oncogenic Ras.
Helfman DM; Pawlak G
J Cell Biochem; 2005 Aug; 95(5):1069-80. PubMed ID: 15962288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]